• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2:基因组学、风险评估、潜在治疗方法和疫苗开发的最新进展。

SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development.

机构信息

Department of Bioinformatics and Biotechnology, Government College University, Faisalabad 38000, Pakistan.

Department of Microbiology and Pharmacy, Abasyn University, Peshawar 25000, Pakistan.

出版信息

Int J Environ Res Public Health. 2021 Feb 8;18(4):1626. doi: 10.3390/ijerph18041626.

DOI:10.3390/ijerph18041626
PMID:33567746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7915969/
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a great threat to public health, being a causative pathogen of a deadly coronavirus disease (COVID-19). It has spread to more than 200 countries and infected millions of individuals globally. Although SARS-CoV-2 has structural/genomic similarities with the previously reported SARS-CoV and MERS-CoV, the specific mutations in its genome make it a novel virus. Available therapeutic strategies failed to control this virus. Despite strict standard operating procedures (SOPs), SARS-CoV-2 has spread globally and it is mutating gradually as well. Diligent efforts, special care, and awareness are needed to reduce transmission among susceptible masses particularly elder people, children, and health care workers. In this review, we highlighted the basic genome organization and structure of SARS-CoV-2. Its transmission dynamics, symptoms, and associated risk factors are discussed. This review also presents the latest mutations identified in its genome, the potential therapeutic options being used, and a brief explanation of vaccine development efforts against COVID-19. The effort will not only help readers to understand the deadly SARS-CoV-2 virus but also provide updated information to researchers for their research work.

摘要

严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)对公共卫生构成巨大威胁,是一种致命的冠状病毒病(COVID-19)的病原体。它已传播到 200 多个国家,感染了全球数百万人。尽管 SARS-CoV-2 在结构/基因组上与以前报告的 SARS-CoV 和 MERS-CoV 有相似之处,但它基因组中的特定突变使其成为一种新型病毒。现有的治疗策略未能控制这种病毒。尽管有严格的标准操作程序(SOP),但 SARS-CoV-2 已在全球范围内传播,并且其也在逐渐发生变异。需要勤奋努力、特别护理和提高认识,以减少易感人群(特别是老年人、儿童和卫生保健工作者)之间的传播。在这篇综述中,我们强调了 SARS-CoV-2 的基本基因组组织和结构。讨论了其传播动态、症状和相关危险因素。本文还介绍了其基因组中最新发现的突变、正在使用的潜在治疗选择以及 COVID-19 疫苗开发工作的简要说明。这一努力不仅有助于读者了解致命的 SARS-CoV-2 病毒,还为研究人员的研究工作提供了最新信息。

相似文献

1
SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development.SARS-CoV-2:基因组学、风险评估、潜在治疗方法和疫苗开发的最新进展。
Int J Environ Res Public Health. 2021 Feb 8;18(4):1626. doi: 10.3390/ijerph18041626.
2
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
3
The 2020 race towards SARS-CoV-2 specific vaccines.2020 年抗击 SARS-CoV-2 特异性疫苗竞赛。
Theranostics. 2021 Jan 1;11(4):1690-1702. doi: 10.7150/thno.53691. eCollection 2021.
4
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
5
Leveraging on the genomics and immunopathology of SARS-CoV-2 for vaccines development: prospects and challenges.利用 SARS-CoV-2 的基因组学和免疫病理学开发疫苗:前景与挑战。
Hum Vaccin Immunother. 2021 Mar 4;17(3):620-637. doi: 10.1080/21645515.2020.1812313. Epub 2020 Sep 16.
6
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics.新型冠状病毒病病毒学、疫苗、变异株和治疗方法的全面综述。
Curr Med Sci. 2021 Dec;41(6):1037-1051. doi: 10.1007/s11596-021-2395-1. Epub 2021 Jul 9.
7
The novel zoonotic COVID-19 pandemic: An expected global health concern.新型人畜共患的新冠疫情:一个意料之中的全球卫生问题。
J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671.
8
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
9
COVID-19 in health-care workers: lessons from SARS and MERS epidemics and perspectives for chemoprophylaxis and vaccines.医护人员中的 COVID-19:SARS 和 MERS 疫情的教训以及化学预防和疫苗的展望。
Expert Rev Vaccines. 2020 Oct;19(10):937-947. doi: 10.1080/14760584.2020.1843432. Epub 2020 Nov 11.
10
The increasing importance of the novel Coronavirus.新型冠状病毒的重要性日益增加。
Hosp Pract (1995). 2021 Feb;49(1):1-11. doi: 10.1080/21548331.2020.1828888. Epub 2020 Oct 20.

引用本文的文献

1
Molecular and Structural Analysis of Specific Mutations from Saudi Isolates of SARS-CoV-2 RNA-Dependent RNA Polymerase and their Implications on Protein Structure and Drug-Protein Binding.SARS-CoV-2 RNA 依赖的 RNA 聚合酶的沙特分离株特定突变的分子和结构分析及其对蛋白质结构和药物-蛋白质结合的影响。
Molecules. 2022 Oct 1;27(19):6475. doi: 10.3390/molecules27196475.
2
Association between multimorbidity, intensive care unit admission, and death in patients with COVID-19 in Brazil: a cross-section study, 2020.巴西 COVID-19 患者的多病共存、重症监护病房收治和死亡之间的关联:一项 2020 年的横断面研究。
Sao Paulo Med J. 2022 Oct 3;141(3):e2022226. doi: 10.1590/1516-3180.2022.0226.R1.21072022. eCollection 2022.
3

本文引用的文献

1
Emergency Tracheal Intubation in Patients with COVID-19: Experience from a UK Centre.2019冠状病毒病患者的紧急气管插管:来自英国一家中心的经验
Anesthesiol Res Pract. 2020 Dec 10;2020:8816729. doi: 10.1155/2020/8816729. eCollection 2020.
2
Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.基于 SARS-COV-2 的新一代多表位疫苗(MEV)的设计:免疫信息学和计算机模拟方法。
PLoS One. 2020 Dec 22;15(12):e0244176. doi: 10.1371/journal.pone.0244176. eCollection 2020.
3
Covid-19: New coronavirus variant is identified in UK.
SARS-CoV-2 Variants Identification: Overview of Molecular Existing Methods.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体鉴定:现有分子方法概述
Pathogens. 2022 Sep 17;11(9):1058. doi: 10.3390/pathogens11091058.
4
Computational Investigations of Traditional Chinese Medicinal Compounds against the Omicron Variant of SARS-CoV-2 to Rescue the Host Immune System.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变种的中药化合物对宿主免疫系统的挽救作用的计算研究
Pharmaceuticals (Basel). 2022 Jun 13;15(6):741. doi: 10.3390/ph15060741.
5
Retrobulbar ocular blood flow and choroidal vascular changes in patients recovering from COVID-19 infection.新冠病毒感染后恢复期患者的眼后段血流和脉络膜血管变化。
Photodiagnosis Photodyn Ther. 2022 Sep;39:102976. doi: 10.1016/j.pdpdt.2022.102976. Epub 2022 Jun 17.
6
Fever, Tachypnea, and Monocyte Distribution Width Predicts Length of Stay for Patients with COVID-19: A Pioneer Study.发热、呼吸急促和单核细胞分布宽度可预测COVID-19患者的住院时间:一项前瞻性研究。
J Pers Med. 2022 Mar 12;12(3):449. doi: 10.3390/jpm12030449.
7
COVID-19-Vaccination-Induced Myocarditis in Teenagers: Case Series with Further Follow-Up.青少年中新冠病毒疫苗接种诱发的心肌炎:进一步随访的病例系列
Int J Environ Res Public Health. 2022 Mar 15;19(6):3456. doi: 10.3390/ijerph19063456.
8
Therapeutic Strategies for COVID-19 Lung Disease in Children.儿童新冠病毒肺炎的治疗策略
Front Pediatr. 2022 Mar 7;10:829521. doi: 10.3389/fped.2022.829521. eCollection 2022.
9
Targeting the RBD of Omicron Variant (B.1.1.529) with Medicinal Phytocompounds to Abrogate the Binding of Spike Glycoprotein with the hACE2 Using Computational Molecular Search and Simulation Approach.利用计算分子搜索和模拟方法,以药用植物化合物靶向奥密克戎变体(B.1.1.529)的受体结合域(RBD),以消除刺突糖蛋白与人类血管紧张素转换酶2(hACE2)的结合。
Biology (Basel). 2022 Feb 7;11(2):258. doi: 10.3390/biology11020258.
10
Rescuing the Host Immune System by Targeting the Immune Evasion Complex ORF8-IRF3 in SARS-CoV-2 Infection with Natural Products Using Molecular Modeling Approaches.利用分子建模方法从天然产物入手,针对 SARS-CoV-2 感染中的免疫逃避复合物 ORF8-IRF3 靶向宿主免疫系统。
Int J Environ Res Public Health. 2021 Dec 23;19(1):112. doi: 10.3390/ijerph19010112.
新冠疫情:英国发现新型冠状病毒变种。
BMJ. 2020 Dec 16;371:m4857. doi: 10.1136/bmj.m4857.
4
Oxford-AstraZeneca COVID-19 vaccine efficacy.牛津大学-阿斯利康新冠疫苗的效力
Lancet. 2021 Jan 9;397(10269):72-74. doi: 10.1016/S0140-6736(20)32623-4. Epub 2020 Dec 8.
5
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
6
Efforts at COVID-19 Vaccine Development: Challenges and Successes.新冠疫苗研发的努力:挑战与成功
Vaccines (Basel). 2020 Dec 6;8(4):739. doi: 10.3390/vaccines8040739.
7
COVID-19 mortality risk for older men and women.COVID-19 对老年男性和女性的死亡率风险。
BMC Public Health. 2020 Nov 19;20(1):1742. doi: 10.1186/s12889-020-09826-8.
8
Variant analysis of 1,040 SARS-CoV-2 genomes.1,040 株 SARS-CoV-2 基因组变异分析。
PLoS One. 2020 Nov 5;15(11):e0241535. doi: 10.1371/journal.pone.0241535. eCollection 2020.
9
COVID-19 case-fatality rate and demographic and socioeconomic influencers: worldwide spatial regression analysis based on country-level data.COVID-19 病死率及其人口统计学和社会经济影响因素:基于国家级数据的全球空间回归分析。
BMJ Open. 2020 Nov 3;10(11):e043560. doi: 10.1136/bmjopen-2020-043560.
10
Overview of the possible role of vitamin C in management of COVID-19.维生素 C 在 COVID-19 管理中可能作用概述。
Pharmacol Rep. 2020 Dec;72(6):1517-1528. doi: 10.1007/s43440-020-00176-1. Epub 2020 Oct 28.